NOD2 polymorphisms in clinical phenotypes of common variable immunodeficiency disorders

被引:15
作者
Packwood, K. [1 ]
Drewe, E. [3 ]
Staples, E. [3 ]
Webster, D. [4 ]
Witte, T. [7 ]
Litzman, J. [8 ]
Egner, W. [5 ]
Sargur, R. [5 ]
Sewell, W. [6 ]
Lopez-Granados, E. [1 ,2 ]
Seneviratne, S. L. [1 ]
Powell, R. J. [3 ]
Ferry, B. L. [1 ]
Chapel, H. M. [1 ,2 ]
机构
[1] Univ Oxford, Oxford Radcliffe Hosp, Dept Immunol, Oxford OX1 2JD, England
[2] Univ Oxford, Nuffield Dept Med, Oxford OX1 2JD, England
[3] Queens Med Ctr, Dept Immunol, Nottingham NG7 2UH, England
[4] Royal Free Hosp, Dept Clin Immunol, London NW3 2QG, England
[5] No Gen Hosp, Dept Immunol, Sheffield S5 7AU, S Yorkshire, England
[6] Dept Immunol, Path Links, Scunthorpe, England
[7] Hannover Med Sch, Dept Clin Immunol & Rheumatol, D-3000 Hannover, Germany
[8] Masaryk Univ, St Anne Univ Hosp, Dept Clin Immunol & Allergol, Brno, Czech Republic
关键词
antibody deficiency; common variable immunodeficiency; disease susceptibility; resistance; polymorphisms; immunodeficiency; -; primary; immunogenetics; INFLAMMATORY-BOWEL-DISEASE; LUNG LYMPHOCYTES-T; CROHNS-DISEASE; CARD15; MUTATIONS; ALVEOLAR MACROPHAGES; SUSCEPTIBILITY LOCI; ACTIVATION; SARCOIDOSIS; VARIANTS; LINKAGE;
D O I
10.1111/j.1365-2249.2010.04216.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P>Common variable immunodeficiency disorders (CVIDs) are a heterogeneous group of diseases characterized by hypogammaglobulinaemia and consequent susceptibility to infection. CVID patients commonly develop a variety of additional manifestations for which the causative factors are not fully understood. Two such manifestations are granulomatous disease and enteropathy. Because the ability to predict complications would aid clinical management, we continue to search for possible disease modifier genes. NOD2 acts a microbial sensor and is involved in proinflammatory signalling. Particular mutations of the NOD2 gene are associated with Crohn's disease including gly908arg, leu1007finsc and arg702trp polymorphisms. We hypothesized that NOD2 polymorphisms may be a disease modifier gene towards an enteropathic or granulomatous phenotype within CVIDs. Sequence-specific primers returned genotypes for 285 CVID patients from centres across the United Kingdom and Europe. We present the frequencies of the different phenotypes of patients within our international cohort. Arg702trp polymorphisms were significantly less frequent than wild-type (WT) (P = 0 center dot 038) among international CVID patients with splenomegaly. Gly908arg polymorphisms were more prevalent than WT in UK patients with autoimmune disorders (P = 0 center dot 049) or enteropathy (P = 0 center dot 049). NOD2 polymorphisms were not more prevalent than WT in CVID patients with clinical phenotypes of granulomata. UK allele frequencies of 0 center dot 014, 0 center dot 056 and 0 center dot 026 were found for gly908arg, arg702trp and leu1007finsc NOD2 polymorphisms, respectively. These do not differ significantly from UK immunocompetent controls confirming, as expected, that in addition these NOD2 polymorphisms do not confer susceptibility to CVIDs per se.
引用
收藏
页码:536 / 541
页数:6
相关论文
共 44 条
[1]   The molecular classification of the clinical manifestations of Crohn's disease [J].
Ahmad, T ;
Armuzzi, A ;
Bunce, M ;
Mulcahy-Hawes, K ;
Marshall, SE ;
Orchard, TR ;
Crawshaw, J ;
Large, O ;
De Silva, A ;
Cook, JT ;
Barnardo, M ;
Cullen, S ;
Welsh, KI ;
Jewell, DP .
GASTROENTEROLOGY, 2002, 122 (04) :854-866
[2]  
BACHWICH PR, 1986, AM J PATHOL, V125, P421
[3]   TACI is mutant in common variable immunodeficiency and IgA deficiency [J].
Castigli, E ;
Wilson, SA ;
Garibyan, L ;
Rachid, R ;
Bonilla, F ;
Schneider, L ;
Geha, RS .
NATURE GENETICS, 2005, 37 (08) :829-834
[4]   Common variable immunodeficiency disorders: division into distinct clinical phenotypes [J].
Chapel, Helen ;
Lucas, Mary ;
Lee, Martin ;
Bjorkander, Janne ;
Webster, David ;
Grimbacher, Bodo ;
Fieschi, Claire ;
Thon, Vojtech ;
Abedi, Mohammad R. ;
Hammarstrom, Lennart .
BLOOD, 2008, 112 (02) :277-286
[5]   Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions [J].
Chapel, Helen ;
Cunningham-Rundles, Charlotte .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (06) :709-727
[6]   Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1q, 3q, and 4q:: Evidence for epistasis between 1p and IBD1 [J].
Cho, JH ;
Nicolae, DL ;
Gold, LH ;
Fields, CT ;
LaBuda, MC ;
Rohal, PM ;
Pickles, MR ;
Qin, L ;
Fu, YF ;
Mann, JS ;
Kirschner, BS ;
Jabs, EW ;
Weber, J ;
Hanauer, SB ;
Bayless, TM ;
Brant, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) :7502-7507
[7]   Diagnostic criteria for primary immunodeficiencies [J].
Conley, ME ;
Notarangelo, LD ;
Etzioni, A .
CLINICAL IMMUNOLOGY, 1999, 93 (03) :190-197
[8]   Common variable immunodeficiency: Clinical and immunological features of 248 patients [J].
Cunningham-Rundles, C ;
Bodian, C .
CLINICAL IMMUNOLOGY, 1999, 92 (01) :34-48
[9]   Common variable immunodeficiency: a review [J].
Di Renzo, M ;
Pasqui, AL ;
Auteri, A .
CLINICAL AND EXPERIMENTAL MEDICINE, 2004, 3 (04) :211-217
[10]  
DREWE E, 2004, CPD B IMMUNOL ALLERG, V4, P20